Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients-Reference-Cited by-同舟云学术

Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients

Published:2012-08-27 Issue:4 Volume:94 Page:345-351
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Marfo Kwaku,Ling Ming,Bao Yi,Calder Brant,Ye Bin,Hayde Nicole,Greenstein Stuart,Chapochnick-Friedman Javier,Glicklich Daniel,de Boccardo Graciela,Kinkhabwala Milan,Akalin Enver

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference20 articles.

1. . Desensitization protocols and their outcome.;Marfo;Clin J Am Soc Nephrol,2011

2. . Desensitization in HLA-incompatible kidney recipients and survival.;Montgomery;N Engl J Med,2011

3. . Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.;Jordan;J Am Soc Nephrol,2004

4. . Rituximab and intravenous immune globulin for desensitization during renal transplantation.;Vo;N Engl J Med,2008

5. . Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.;Vo;Transplantation,2010

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of Pre-transplant Panel-Reactive Antibody on Post-transplantation Outcomes: A Study of Nationwide Heart Transplant Registry Data;Korean Circulation Journal;2024

2. Immunoadsorption-Based HLA Desensitization in Patients Awaiting Deceased Donor Kidney Transplantation: An Interventional, Non-Randomised, Single Cohort Study;Transplant International;2023-08-23

3. Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial;Kidney360;2023-03-23

4. The Highly Sensitized Recipient;Clinics in Chest Medicine;2023-03

5. Point-Counterpoint: Desensitization to improve the likelihood of lung transplantation;Human Immunology;2023-01